These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16822103)

  • 1. Comorbidity, case complexity, and effects of evidence-based treatment for children referred for disruptive behavior.
    Kazdin AE; Whitley MK
    J Consult Clin Psychol; 2006 Jun; 74(3):455-67. PubMed ID: 16822103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic alliance in cognitive-behavioral treatment of children referred for oppositional, aggressive, and antisocial behavior.
    Kazdin AE; Marciano PL; Whitley MK
    J Consult Clin Psychol; 2005 Aug; 73(4):726-30. PubMed ID: 16173860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Child-therapist and parent-therapist alliance and therapeutic change in the treatment of children referred for oppositional, aggressive, and antisocial behavior.
    Kazdin AE; Whitley M; Marciano PL
    J Child Psychol Psychiatry; 2006 May; 47(5):436-45. PubMed ID: 16671927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of child-therapist alliance in cognitive-behavioral treatment of children referred for oppositional and antisocial behavior.
    Kazdin AE; Durbin KA
    Psychotherapy (Chic); 2012 Jun; 49(2):202-17. PubMed ID: 22642524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study.
    Biederman J; Petty CR; Dolan C; Hughes S; Mick E; Monuteaux MC; Faraone SV
    Psychol Med; 2008 Jul; 38(7):1027-36. PubMed ID: 18205967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidity as a predictor and moderator of treatment outcome in youth with anxiety, affective, attention deficit/hyperactivity disorder, and oppositional/conduct disorders.
    Ollendick TH; Jarrett MA; Grills-Taquechel AE; Hovey LD; Wolff JC
    Clin Psychol Rev; 2008 Dec; 28(8):1447-71. PubMed ID: 18973971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Callous-unemotional traits are associated with clinical severity in referred boys with conduct problems.
    Enebrink P; Andershed H; Långström N
    Nord J Psychiatry; 2005; 59(6):431-40. PubMed ID: 16316895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADHD with comorbid oppositional defiant disorder or conduct disorder: discrete or nondistinct disruptive behavior disorders?
    Connor DF; Doerfler LA
    J Atten Disord; 2008 Sep; 12(2):126-34. PubMed ID: 17934178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopathy and comorbidity in a young offender sample: taking a closer look at psychopathy's potential importance over disruptive behavior disorders.
    Salekin RT; Leistico AM; Neumann CS; DiCicco TM; Duros RL
    J Abnorm Psychol; 2004 Aug; 113(3):416-27. PubMed ID: 15311987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical presentation and treatment outcome for children with comorbid externalizing and internalizing symptoms.
    Chase RM; Eyberg SM
    J Anxiety Disord; 2008; 22(2):273-82. PubMed ID: 17467229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of psychoanalysis for children with disruptive disorders.
    Fonagy P; Target M
    J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):45-55. PubMed ID: 8138520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Science to practice in underserved communities: the effectiveness of school mental health programming.
    Owens JS; Murphy CE; Richerson L; Girio EL; Himawan LK
    J Clin Child Adolesc Psychol; 2008 Apr; 37(2):434-47. PubMed ID: 18470779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oppositional defiant disorder.
    Hamilton SS; Armando J
    Am Fam Physician; 2008 Oct; 78(7):861-6. PubMed ID: 18841736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifetime prevalence, correlates, and persistence of oppositional defiant disorder: results from the National Comorbidity Survey Replication.
    Nock MK; Kazdin AE; Hiripi E; Kessler RC
    J Child Psychol Psychiatry; 2007 Jul; 48(7):703-13. PubMed ID: 17593151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based psychosocial treatments for children and adolescents with disruptive behavior.
    Eyberg SM; Nelson MM; Boggs SR
    J Clin Child Adolesc Psychol; 2008 Jan; 37(1):215-37. PubMed ID: 18444059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conduct disorder in referred children and adolescents: clinical and therapeutic issues.
    Masi G; Milone A; Manfredi A; Pari C; Paziente A; Millepiedi S
    Compr Psychiatry; 2008; 49(2):146-53. PubMed ID: 18243886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between anxiety and externalizing disorders in youth: the influences of age and gender.
    Marmorstein NR
    J Anxiety Disord; 2007; 21(3):420-32. PubMed ID: 16875798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood disruptive behaviors and family functioning in clinically referred children: are girls different from boys?
    Fossum S; Mørch WT; Handegård BH; Drugli MB
    Scand J Psychol; 2007 Oct; 48(5):375-82. PubMed ID: 17877552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
    Bangs ME; Hazell P; Danckaerts M; Hoare P; Coghill DR; Wehmeier PM; Williams DW; Moore RJ; Levine L;
    Pediatrics; 2008 Feb; 121(2):e314-20. PubMed ID: 18245404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three dimensions of oppositionality in youth.
    Stringaris A; Goodman R
    J Child Psychol Psychiatry; 2009 Mar; 50(3):216-23. PubMed ID: 19166573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.